Behind every sample is a patient and family awaiting a high-quality, timely result.
…which is why US LABS stays well ahead of emerging science. We are the nation’s esoteric oncology laboratory.The communities we serve expect us to be an innovation leader. And every day we deliver, with great accuracy, information connectivity and high speed. Whatever your role in the patient care continuum, the reliable services of US LABS will save you time and optimize your performance.
What's New
BreastOncPx™ can be used to estimate the likelihood of disease recurrence including metastasis in node-negative (N-), ER-positive (ER+) breast cancer patients.KRAS and BRAF mutation status has been shown to provide prognostic and potentially predictive information for patients considered for anti-EGFR monoclonal antibody therapies.
FDA, ASCO, and NCCN issue statements supporting KRAS testing
Circulating Tumor Cells for Metastatic Cancer - Breast, Colorectal, or Prostate
PNH Evaluation by flow cytometry: High-sensitivity flow from US LABS allows for detection of smaller PNH clones than standard flow cytometry.
Events & Education
CAP 2010
Hyatt Regency Chicago
Chicago, IL
September 26 - 27
Chicago, IL
September 26 - 27
Join us for a dinner workshop on Companion Diagnostics and Targeted Therapies in Oncology.
Visit www.cap.org/cap10 for details and to register.
